Advances in psoriasis treatment

被引：23
作者：
Schön, MP [1 ]
机构：
[1] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97078 Wurzburg, Germany
[2] Univ Wurzburg, Dept Dermatol, D-97078 Wurzburg, Germany
来源：
LANCET | 2005年 / 366卷 / 9494期
关键词：
D O I：
10.1016/S0140-6736(05)67542-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1333 / 1335
页数：3
相关论文
共 18 条
[1]   Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial [J].
Antoni, C ;
Krueger, GG ;
de Vlam, K ;
Birbara, C ;
Beutler, A ;
Guzzo, C ;
Zhou, B ;
Dooley, LT ;
Kavanaugh, A .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1150-1157
[2]   Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial [J].
Feldman, SR ;
Gordon, KB ;
Bala, M ;
Evans, R ;
Li, S ;
Dooley, LT ;
Guzzo, C ;
Patel, K ;
Menter, A ;
Gottlieb, AB .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (05) :954-960
[3]   Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial [J].
Gottlieb, AB ;
Evans, R ;
Li, S ;
Dooley, LT ;
Guzzo, CA ;
Baker, D ;
Bala, M ;
Marano, CW ;
Menter, A .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (04) :534-542
[4]   Psoriasis: Emerging therapeutic strategies [J].
Gottlieb, AB .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (01) :19-34
[5]   Infectious complications of treatment with biologic agents [J].
Hamilton, CD .
CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (04) :393-398
[6]  
Krueger G, 2001, ARCH DERMATOL, V137, P280
[7]   Immunologic targets in psoriasis [J].
Kupper, TS .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21) :1987-1990
[8]   Psoriasis [J].
Lebwohl, M .
LANCET, 2003, 361 (9364) :1197-1204
[9]  
MUELLER W, 1979, NEW ENGL J MED, V301, P555
[10]   Treatment with anti-tumor necrosis factor α (TNF-α) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions [J].
Oh, CJ ;
Das, KM ;
Gottlieb, AB .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (05) :829-830
12